beta-adrenoceptor antagonism and intraocular pressure. A clinical study on propranolol, practolol and atenolol.
D000284:Administration, Oral; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001262:Atenolol / Q000008:administration & dosage / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use; D011217:Practolol / Q000008:administration & dosage / Q000009:adverse effects; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D014065:Tonometry, Ocular
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D010862:Pilocarpine; D001262:Atenolol; D011433:Propranolol; D011217:Practolol